Pantoprazole
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Pantoprazole and local guidelines before prescribing.
Proton pump inhibitor
Mechanism
Proton pump inhibitor.
Uses
GORD, peptic ulcer, gastroprotection with NSAIDs.
Dosing
- Clopidogrel (75 mg) - prodrug activated by CYP2C19 (poor metabolisers respond less; omeprazole may reduce effect - use lansoprazole or pantoprazole); irreversible.
Cardiology: Anatomy Physiology and Pharmacology - Lansoprazole 30 mg once daily | Alternative full-dose PPI; preferred with clopidogrel (with pantoprazole). Linked to microscopic colitis.
Gastroenterology: Oesophagus and Stomach
Side effects
Headache, diarrhoea, hypomagnesaemia, B12 deficiency, fracture risk, C. difficile.
Interactions
Lower CYP2C19 inhibition so less effect on clopidogrel; reduces iron and levothyroxine absorption.
Contraindications and cautions
Atazanavir co-prescription
Monitoring
Magnesium, B12 long term
Pregnancy and breastfeeding
Acceptable
Renal and hepatic impairment
Reduce dose in severe liver impairment
Overdose and reversal
Supportive
Special advice
Review long-term need; IV form available.
More from the textbook: uses, cautions and other points
- Omeprazole and esomeprazole inhibit CYP2C19 → less activation of clopidogrel (avoid the combination - use lansoprazole or pantoprazole).
Gastroenterology: Anatomy Physiology Pharmacology - Recurrent stent thrombosis in a patient on clopidogrel and omeprazole | CYP2C19 interaction - switch to lansoprazole or pantoprazole
Gastroenterology: Anatomy Physiology Pharmacology - Clopidogrel: Omeprazole and esomeprazole reduce its activation - use lansoprazole or pantoprazole instead.
Gastroenterology: Oesophagus and Stomach - Give PPI protection to high-risk NSAID or aspirin users; use lansoprazole or pantoprazole with clopidogrel.
Gastroenterology: Oesophagus and Stomach - Clopidogrel - a prodrug activated by CYP2C19 (poor metabolisers and omeprazole or esomeprazole reduce its effect - use lansoprazole or pantoprazole); used after stroke, in peripheral arterial disease and with aspirin after ACS or stents.
Haematology: Anatomy Physiology and Pharmacology - Gastroprotection - PPI for people on antiplatelets with GI risk factors (lansoprazole or pantoprazole with clopidogrel).
Haematology: Haemostasis and Thrombosis
Where it is discussed in the book
- Cardiology: Anatomy Physiology and Pharmacology (1 mention)
- Gastroenterology: Anatomy Physiology Pharmacology (3 mentions)
- Gastroenterology: Oesophagus and Stomach (3 mentions)
- Haematology: Anatomy Physiology and Pharmacology (1 mention)
- Haematology: Haemostasis and Thrombosis (1 mention)